[HTML][HTML] Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence
In aging mice, osteoclast number increases in cortical bone but declines in trabecular bone,
suggesting that different mechanisms underlie age-associated bone loss in these 2 …
suggesting that different mechanisms underlie age-associated bone loss in these 2 …
[HTML][HTML] The redox-senescence axis and its therapeutic targeting
NYL Ngoi, AQX Liew, SJF Chong, MS Davids… - Redox Biology, 2021 - Elsevier
Significance Cellular growth arrest, associated with 'senescence', helps to safeguard against
the accumulation of DNA damage which is often recognized as the underlying mechanism of …
the accumulation of DNA damage which is often recognized as the underlying mechanism of …
Senolytic treatment alleviates doxorubicin‐induced chemobrain
V Budamagunta, A Kumar, A Rani… - Aging cell, 2024 - Wiley Online Library
Doxorubicin (Dox), a widely used treatment for cancer, can result in chemotherapy‐induced
cognitive impairments (chemobrain). Chemobrain is associated with inflammation and …
cognitive impairments (chemobrain). Chemobrain is associated with inflammation and …
Potential role of polyphenolic flavonoids as senotherapeutic agents in degenerative diseases and geroprotection
Cellular senescence, a hallmark of ageing, contributes to tissue or organ dysfunction and
the pathophysiology of diverse age-related diseases (ARD) by various mechanisms …
the pathophysiology of diverse age-related diseases (ARD) by various mechanisms …
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
S Morsli, GJ Doherty, D Muñoz-Espín - Mechanisms of Ageing and …, 2022 - Elsevier
Pharmacologically active compounds that manipulate cellular senescence (senotherapies)
have recently shown great promise in multiple pre-clinical disease models, and some of …
have recently shown great promise in multiple pre-clinical disease models, and some of …
[HTML][HTML] Current senolytics: mode of action, efficacy and limitations, and their future
AN Rad, J Grillari - Mechanisms of Ageing and Development, 2023 - Elsevier
Senescence is a cellular state characterized by its near-permanent halted cell cycle and
distinct secretory phenotype. Although senescent cells have a variety of beneficial …
distinct secretory phenotype. Although senescent cells have a variety of beneficial …
Senolytic targets and new strategies for clearing senescent cells
M Ge, L Hu, H Ao, M Zi, Q Kong, Y He - Mechanisms of Ageing and …, 2021 - Elsevier
Senescent cells (SCs) accumulate with age and cause various age-related diseases.
Clearance of SCs by transgenic or pharmaceutical strategies has been demonstrated to …
Clearance of SCs by transgenic or pharmaceutical strategies has been demonstrated to …
Cellular senescence: mechanisms and therapeutic potential
Z Liao, HL Yeo, SW Wong, Y Zhao - Biomedicines, 2021 - mdpi.com
Cellular senescence is a complex and multistep biological process which cells can undergo
in response to different stresses. Referring to a highly stable cell cycle arrest, cellular …
in response to different stresses. Referring to a highly stable cell cycle arrest, cellular …
Senotherapeutics: Targeting senescent cells for the main age-related diseases
V Boccardi, P Mecocci - Mechanisms of ageing and development, 2021 - Elsevier
Highlights•Cellular senescence is the biological central mechanism for the major age-
related diseases.•A large number of molecules, including synthetic senolytic and natural …
related diseases.•A large number of molecules, including synthetic senolytic and natural …
DNA damage-but not enzalutamide-induced senescence in prostate cancer promotes senolytic Bcl-xL inhibitor sensitivity
N Malaquin, A Vancayseele, S Gilbert… - Cells, 2020 - mdpi.com
Cellular senescence is a natural tumor suppression mechanism defined by a stable
proliferation arrest. In the context of cancer treatment, cancer cell therapy-induced …
proliferation arrest. In the context of cancer treatment, cancer cell therapy-induced …